Literature DB >> 8123228

Effects of intraventricular taurine, homotaurine and GABA on serum prolactin and thyrotropin levels in female and in male rats.

M Mäkinen1, L Ahtee, K Rosenqvist, R K Tuominen, P Männistö.   

Abstract

Serum prolactin and thyrotropin levels of conscious, unrestrained male and female rats were compared after intracerebroventricular (i.c.v.) administration of taurine, gamma-aminobutyric acid (GABA) and homotaurine. The amino acids studied had no clear effect on serum basal thyrotropin levels in male or female rats. All amino acids elevated serum prolactin levels in female rats at the dose of 5 mumol/rat; homotaurine by about 18-fold, taurine and GABA by 3-fold. Only homotaurine elevated serum prolactin of male rats at this dose, but its effect was less pronounced (p < 0.01) in male than in female rats. Although homotaurine was clearly more potent than the two other amino acids, at the dose of 10 mumol/rat taurine and GABA also elevated serum prolactin in male rats. These findings show that there are gender-related differences in the responses of serum prolactin levels to homotaurine, taurine and GABA in rats. The tuberoinfundibular dopaminergic pathway, which exerts tonic inhibitory influence on prolactin secretion, is sexually differentiated. Hence the gender-related differences in the effects of the amino acids on prolactin secretion suggest that they might inhibit dopamine release from the median eminence. In case of homotaurine, the gender effect was most pronounced. The less clear dependence of GABA's effect on the gender is in accordance with the suggestions that GABA influences the secretion of serum prolactin by more than one mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8123228     DOI: 10.1007/bf01277021

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  32 in total

1.  The bioassay of thyrotropin in serum.

Authors:  J M McKENZIE
Journal:  Endocrinology       Date:  1958-09       Impact factor: 4.736

Review 2.  The rat as model for the study of drug effects on thyroid function: consideration of methodological problems.

Authors:  K D Döhler; C C Wong; A von zur Mühlen
Journal:  Pharmacol Ther B       Date:  1979

3.  Dual gamma-aminobutyric acid control of prolactin secretion in the rat.

Authors:  V Locatelli; D Cocchi; C Frigerio; R Betti; P Krogsgaard-Larsen; G Racagni; E E Müller
Journal:  Endocrinology       Date:  1979-09       Impact factor: 4.736

4.  Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat.

Authors:  A O Donoso; W Bishop; C P Fawcett; L Krulich; S M McCann
Journal:  Endocrinology       Date:  1971-09       Impact factor: 4.736

5.  Taurine and its derivatives alter brain dopamine metabolism similarly to GABA in mice and rats.

Authors:  L Ahtee; M L Vahala
Journal:  Prog Clin Biol Res       Date:  1985

6.  The effect of taurine on motor behaviour, body temperature and monoamine metabolism in rat brain.

Authors:  J Garcia de Yebenes Prous; A Carlsson; M A Mena Gomez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-09       Impact factor: 3.000

7.  Bio-assay of prolactin. Analysis of the pigeon crop-sac response to local prolactin injection by an objective and quantitative method.

Authors:  C S Nicoll
Journal:  Endocrinology       Date:  1967-04       Impact factor: 4.736

8.  Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes.

Authors:  N G Bowery; D R Hill; A L Hudson
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

9.  Sex-related difference in the release of dopamine into hypophysial portal blood.

Authors:  G A Gudelsky; J C Porter
Journal:  Endocrinology       Date:  1981-11       Impact factor: 4.736

10.  Dopamine in hypophysial portal plasma of the rat during the estrous cycle and throughout pregnancy.

Authors:  N Ben-Jonathan; C Oliver; H J Weiner; R S Mical; J C Porter
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.